Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Hearn

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2010
Osteoporosis in multiple sclerosisAndrew P Hearn, Eli Silber
Current Opinion in Immunology|November 19, 2020
Biologic treatment options for severe asthmaAndrew P Hearn, Brian D Kent, David J Jackson
Breathe (Sheffield, England)|March 17, 2022
A pragmatic guide to choosing biologic therapies in severe asthmaJoanne E Kavanagh, Andrew P Hearn, David J Jackson
Allergy|June 19, 2026
Algorithms in Allergy: Diagnosis of Concomitant Inducible Laryngeal Obstruction in Adults With AsthmaAndrew P Hearn, Claire Slinger, Jennifer M Butler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 3, 2022
The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti-IL-5R treatmentAndrew P Hearn, Michelle S Mak, Irilda Budaj, et al.
Allergy|May 1, 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumabCharles H R Francis, Andrew P Hearn, Sharenja Ratnakumar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2010
Osteoporosis in multiple sclerosisAndrew P Hearn, Eli Silber
Current Opinion in Immunology|November 19, 2020
Biologic treatment options for severe asthmaAndrew P Hearn, Brian D Kent, David J Jackson
Breathe (Sheffield, England)|March 17, 2022
A pragmatic guide to choosing biologic therapies in severe asthmaJoanne E Kavanagh, Andrew P Hearn, David J Jackson
Allergy|June 19, 2026
Algorithms in Allergy: Diagnosis of Concomitant Inducible Laryngeal Obstruction in Adults With AsthmaAndrew P Hearn, Claire Slinger, Jennifer M Butler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 3, 2022
The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti-IL-5R treatmentAndrew P Hearn, Michelle S Mak, Irilda Budaj, et al.
Allergy|May 1, 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumabCharles H R Francis, Andrew P Hearn, Sharenja Ratnakumar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
Pageof 2